Wednesday, December 18, 2019
Federal Circuit Upholds $70 Million Judgment for Amgen in Epogen Biosimilar Case
Federal Circuit Upholds $70 Million Judgment for Amgen in Epogen Biosimilar Case: Yesterday, in an opinion authored by Judge Moore, the Court of Appeals for the Federal Circuit (CAFC) affirmed the District of Delaware’s decision that in part affirmed a $70 million jury verdict for Amgen regarding infringement of its biosimilar, Epogen.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment